When we talk about health security, we often focus on hospitals and doctors. But access to medicine starts much earlier — in manufacturing plants, distribution networks, and the companies willing to invest in getting high-demand drugs to people in a timely way. Grupo Neolpharma, an IFC investee based in Mexico, is doing exactly that. With 3,300 employees and medicines exported to 12 countries, they’re proving that a locally-grown pharmaceutical company can serve millions across Latin America — at prices 65% lower than the cost of patented products. “The absence of local manufacturing shouldn’t be a reason why you get stuck with old technologies as others advance.” — Santiago Cornejo, PAHO. Read how IFC is helping to build a stronger pharmaceutical ecosystem across Latin America and the Caribbean ➡️ http://wrld.bg/sVYP50YLePf
IFC - International Finance Corporation’s Post
More from this author
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
Super